Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00648271 | Fed Study of Metoprolol Tartrate Tablets 25 mg and Lopressor® 50 mg | PHASE1 | COMPLETED | 19 | — | — | Dec 1, 2002 | Jan 1, 2003 | Apr 23, 2024 | 1 | United States |
| NCT00649116 | Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mg | PHASE1 | COMPLETED | 20 | — | — | Dec 1, 2002 | Jan 1, 2003 | Apr 23, 2024 | 1 | United States |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Metoprolol Tartrate Tablets 25 mg |
| 2 | ACTIVE_COMPARATOR | Lopressor® Tablets 50 mg |
| Name | Type | Description |
|---|---|---|
| Metoprolol Tartrate Tablets 25 mg | DRUG | 2x50mg, single dose fed |
| Lopressor® Tablets 50 mg | DRUG | 1x50mg, single dose fed |
| Metoprolol Tartrate Tablets 100 mg | DRUG | 100mg, single dose fed |
| Lopressor® Tablets 100 mg | DRUG | 100mg, single dose fed |
Inclusion Criteria: 1. Age: 18 years and older. 2. Sex: Male and non-pregnant, non-lactating female 1. Women of childbearing potential must have negative serum beta-human chorionic gonadotropin (HCG) pregnancy tests performed within 14 days prior to the start of the study and the evening prior ...